By Tom Winnifrith | Tuesday 26 October 2021
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I deal with Skinbiotherapeutics (SBTX) first. Then it is onto Yourgene (YGEN) and its trading statement, Eurasia (EUA) and a two year farce and finally the bid for Arden (ARDN) by Ince Group (INCE) and what to make of it all. I feel uncomfortable for reasons I explain.